Save Comparison | ![]() Recursion Pharmaceuticals Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology. | ![]() BenevolentAI BenevolentAI is a company engaged in the development and application of artificial intelligence for drug discovery and development. | ![]() Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics. | ![]() Intellia Therapeutics Intellia is developing therapeutic products to help people with genetic diseases. | ![]() CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. |
Founding Date | Founding Date 2013 | Founding Date 2013 | Founding Date 1980 | Founding Date 2014 | Founding Date 2013 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Salt Lake City, US HQ | Locations London, GB HQ Babraham, GB Brooklyn, US | Locations Cambridge, US HQ Boulogne Billancourt, FR Berlin, DE Dublin, IE Milano, IT Chiyoda City, JP see more | Locations Cambridge, US HQ | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US |
Employees | Employees 1913% increase | Employees 2761% decrease | Employees 74349% increase | Employees 27028% increase | Employees 30462% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1 b | Valuation ($) 7.6 b | Valuation ($) 4.8 b | Valuation ($) 14.2 b |
Twitter followers | Twitter followers 3.8 k | Twitter followers 6.5 k | Twitter followers 3 k | Twitter followers 5.8 k | Twitter followers 10.9 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 36 | Number of tweets (last 30 days) 16 | Number of tweets (last 30 days) 12 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 22.5 | Average likes per tweet (last 30 days) 3.6 | Average likes per tweet (last 30 days) 15.8 | Average likes per tweet (last 30 days) 12.4 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 94.44% | Percentage of tweets with engagement (last 30 days) 93.75% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 292115 | Alexa Website Rank 280386 | Alexa Website Rank 315290 | Alexa Website Rank 264531 | Alexa Website Rank 190330 |
Employee Rating | Employee Rating 4.7 | Employee Rating 3.8 | Employee Rating 3.6 | Employee Rating 3.7 | Employee Rating 3.3 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £6.8m (FY, 2018) | Revenue (est.) $380.8m (FY, 2019) | Revenue (est.) $43.1m (FY, 2019) | Revenue (est.) $289.6m (FY, 2019) |
Gross profit | Gross profit N/A | Gross profit £6.8m (FY, 2018) | Gross profit N/A | Gross profit $43.1m (FY, 2019) | Gross profit N/A |
Net income | Net income N/A | Net income (£26.9m) (FY, 2018) | Net income ($715.1m) (FY, 2019) | Net income ($99.5m) (FY, 2019) | Net income $66.9m (FY, 2019) |
Funding | |||||
Latest funding round | Latest funding round $ 239m (5 months ago) | Latest funding round $ 90m (over 1 year ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 437.1m | Total funding raised $ 305m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 127m |
BenevolentAI is a company engaged in the development and application of artificial intelligence for drug discovery and development.
View companySarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
View companyIntellia is developing therapeutic products to help people with genetic diseases.
View companyCRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View company